February 27, 2012 - Belanoff Interview: Market size and Pricing
This is clearly confirmation of everything good I had heard so far and it's directly from the President of the company!
I guess what's not clear to me is the medical insurance reimbursement. I think once that is clearly addressed favorably, this stock is an instant double. Does anyone have any information at all on the insurance reimbursement on this, or at least where we should set our expectations. I haven't researched any Cushings websites, but I'm certain that's a big issue that they might already be speaking out on.
Not sure how many people with Cushings are considered as having an existing condition and how the insurance companies will look at that. I'm sure they will try to avoid putting out $100K a year on drugs.
Once the product is approved and price is set most insurers have an internal review of the product (P&T committee) before they will cover/reimburse it. This typically takes 6-9 months once the process has begun. Most manufacturers push insurers to start this process prior to approval. IMO these guys should have had pricing locked down months ago.